Your browser doesn't support javascript.
loading
Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma.
Lue, Hui-Wen; Derrick, Daniel S; Rao, Soumya; Van Gaest, Ahna; Cheng, Larry; Podolak, Jennifer; Lawson, Samantha; Xue, Changhui; Garg, Devin; White, Ralph; Ryan, Christopher W; Drake, Justin M; Ritz, Anna; Heiser, Laura M; Thomas, George V.
Afiliación
  • Lue HW; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Derrick DS; Department of Biomedical Engineering, Oregon Health and Science University Center for Spatial Systems Biomedicine, Portland, OR, USA.
  • Rao S; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Van Gaest A; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Cheng L; Graduate Program in Quantitative Biomedicine, Rutgers University, Piscataway, NJ, USA.
  • Podolak J; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Lawson S; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Xue C; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Garg D; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • White R; Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA.
  • Ryan CW; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
  • Drake JM; Division of Hematology and Oncology, Oregon Health and Science University, Portland, OR, USA.
  • Ritz A; Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA.
  • Heiser LM; Department of Urology, University of Minnesota, Minneapolis, MN, USA.
  • Thomas GV; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
Cell Rep Med ; 2(5): 100267, 2021 05 18.
Article en En | MEDLINE | ID: mdl-34095877

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Carcinoma de Células Renales / Dasatinib / Anilidas Límite: Humans Idioma: En Revista: Cell Rep Med Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Carcinoma de Células Renales / Dasatinib / Anilidas Límite: Humans Idioma: En Revista: Cell Rep Med Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos